Keep in Touch

© 2016 by Progenerative Medical, Inc.

Progenerative Medical

Progenerative Medical is translating clinically-proven Reduced Pressure Therapy to orthopedic indications. 

  • LinkedIn Social Icon
  • Twitter Social Icon
 
 

Leadership Team

James W. Poser, PhD

CEO

Dr. Poser has over 35 years of experience in medical device product development and commercialization.  He has held executive positions with Sulzer Orthopedics, Osteotech, Orquest, Stryker Orthopedics, IsoTis Orthobiologics, Kinetic Concepts, SpineSmith and Bone Bank Allografts, and has shepherded several start-up and early-stage companies through product development, approval and successful commercial launch.  Two of the companies Dr. Poser started have been acquired by major orthopedic device companies

Neal K. Vail, PhD

CTO

Dr. Vail has over 20 years of experience in medical device and pharmaceutical product R&D and commercialization.  He has held leadership positions at NEC America, Inc., DaimlerBenz, Biomedical Enterprises, SwRI, and Kinetic Concepts.  He has assembled cross-functional teams to execute successful product development programs funded through corporate, private and public stakeholders.  He has been a business strategy and technology advisor to several medical device start-ups.  Dr. Vail has authored several publications and issued patents.

Larry D. Swain, DDS, MS

VP R&D

Dr. Swain, in addition to clinical training, has over 30 years' experience in translational research focused on musculoskeletal, spine and soft tissue regeneration and repair.  He is a recognized expert in bone and cartilage development, regeneration, and healing.  He has provided counsel to organizations pursuing orthopedic materials and devices, bone active drugs, and wound healing strategies, including appearing on their behalf before the FDA.  Dr. Swain is an author on numerous Regenn™ Therapy patents and related publications.  He also has academic and governmental-agency affiliations.

Press

2016

September 14, 2016

Progenerative Medical Obtains Exclusive Rights to Tissue Regeneration Technology

Progenerative Medical to develop and commercialize negative pressure therapies for the spine and general orthopedics.

1 / 1

Please reload

 

Learn More